摘要
【摘要】目的:研究富马酸喹硫平片、丙戊酸镁缓释片分别联合碳酸锂治疗双相情感障碍躁狂发作的疗效。方法:根据“双盲随机分组原则”将本院接收的双相情感障碍躁狂发作患者100例分为对照组和观察组,50例/组,前一组采取丙戊酸镁缓释片联合碳酸锂治疗,后一组实施富马酸喹硫平片联合碳酸锂治疗。将两组双相情感障碍躁狂发作患者的BRMS评分、PANSS评分、认知功能、临床效果、不良反应发生情况进行比对。结果:观察组双相情感障碍躁狂发作患者治疗后的BRMS评分及PANSS评分均低于对照组,差异具有统计学意义(P<0.05);治疗后的HVLT-R、CPT评分高于对照组,差异具有统计学意义(P<0.05);两组的临床总有效率和不良反应发生情况进行比较差异无统计学意义(P>0.05)。结论:在治疗双相情感障碍躁狂发作方面,富马酸喹硫平片联合碳酸锂、丙戊酸镁缓释片联合碳酸锂进行治疗均可取得较好的疗效,安全性较高,但是富马酸喹硫平片联合碳酸锂在改善患者认知功能及临床症状方面更胜一筹。
关键词:【关键词】:双相情感障碍;躁狂发作;富马酸喹硫平片;丙戊酸镁缓释片;碳酸锂
ABSTRACT
[Abstract] Objective: To study the efficacy of quetiapine fumarate and magnesium valproate sustained release tablets combined with lithium carbonate in the treatment of bipolar disorder manic attacks. Methods: According to the principle of "double blind randomized grouping", 100 patients with bipolar disorder manic attacks received in our hospital were divided into the control group and the observation group, 50 patients/group, the former group was treated with magnesium valproate sustained release tablets combined with lithium carbonate, and the latter group was treated with quetiapine fumarate tablets combined with lithium carbonate. BRMS scores, PANSS scores, cognitive function, clinical outcomes, and adverse reactions were compared between the two groups. Results: After treatment, BRMS and PANSS scores of patients with bipolar disorder manic-episode in the observation group were lower than those in the control group, with statistically significant differences (P<0.05). After treatment, hvlt-r and CPT scores were higher than those of the control group, and the difference was statistically significant (P<0.05). There was no significant difference between the two groups in the total clinical efficiency and adverse reactions (P>0.05). Conclusion : Quetiapine fumarate combined with lithium carbonate and magnesium valproate sustained-release tablets combined with lithium carbonate are effective and safe in the treatment of bipolar disorder manic attacks, but quetiapine fumarate combined with lithium carbonate is superior in improving the cognitive function and clinical symptoms of patients.
Key words: [key words] : Bipolar disorder; Manic episodes; Quetiapine fumarate tablets; Magnesium valproate sustained release tablets; Lithium carbonate
引用本文 / How to Cite This Article
李芳,范悦斌,张育芬,陈巧灵.富马酸喹硫平片、丙戊酸镁缓释片分别联合碳酸锂治疗双相情感障碍躁狂发作的疗效[J]. 国际精神病学杂志, 2019, 46(1): 81-83
参考文献
- 利培酮联合小剂量碳酸锂对老年期慢性精神分裂症的效果及不良反应观察.
- 双相障碍躁狂发作治疗前后血清尿酸水平分析.
- 喹硫平与丙戊酸镁缓释片治疗双相障碍抑郁发作的对照研究.
- 齐拉西酮结合丙戊酸钠治疗双相障碍躁狂发作的效果分析.
- 喹硫平联合碳酸锂对双相情感障碍躁狂发作患者认知功能及血清生化指标的影响.
- 富马酸喹硫平片或丙戊酸镁缓释片联合碳酸锂治疗双相情感障碍躁狂发作的临床研究.
- 双相情感障碍躁狂发作的疗效及安全性评价.
- 心境稳定剂合并右前额皮质rTMS治疗双相障碍躁狂发作患者的疗效研究.
- 喹硫平治疗双相情感障碍的临床效果观察.
- 齐拉西酮合并碳酸锂治疗双相情感障碍躁狂发作的临床疗效及安全性评价.
- 齐拉西酮联合心境稳定剂治疗双相情感障碍Ⅰ型急性躁狂或混合发作的疗效分析.
- 冲动性在双相I型障碍躁狂发作认知功能损害中的作用分析.
- 阿戈美拉汀联合碳酸锂缓释片治疗双相抑郁的疗效研究.
- 血清同型半胱氨酸水平对双相障碍躁狂发作女性患者认知功能的影响.
- 奎硫平治疗精神科双相急性躁狂症患者的疗效及安全性.
- 丙戊酸钠针剂与片剂治疗双相情感障碍躁狂发作的疗效观察.
- 血清CD30、BAFF、sTNF-R1、CXCL10与双相障碍不同情绪状态的相关性.
- 富马酸喹硫平片对首发精神分裂症患者血清神经细胞因子及神经电生理参数的影响.
- 丙戊酸钠联合喹硫平治疗双相情感障碍躁狂发作患者的安全性和有效性评价.
- 碳酸锂治疗白细胞减少致重度锂盐中毒1例.
- 团体认知行为疗法联合药物控制对双相情感障碍患者躁狂发作、氧化应激指标及睡眠质量的影响.
- 丙戊酸镁联合喹硫平治疗双相情感障碍躁狂发作的临床疗效.
- 齐拉西酮联合碳酸锂治疗双相情感障碍Ⅰ型急性躁狂发作患者疗效及对血清Hcy、BDNF水平和认知功能的影响.
- 利培酮联合丙戊酸钠与碳酸锂治疗伴攻击行为精神分裂症的疗效比较.
- 丙戊酸钠或齐拉西酮联合碳酸锂治疗双相情感障碍狂躁发作的疗效对比.
- 双相Ⅰ型障碍躁狂发作患者复发的Logistic回归分析.
- 奥氮平与碳酸锂对双相情感障碍患者躁狂症状、血清尿酸水平的影响及安全性比较.